JP2007169302A5 - - Google Patents

Download PDF

Info

Publication number
JP2007169302A5
JP2007169302A5 JP2007083117A JP2007083117A JP2007169302A5 JP 2007169302 A5 JP2007169302 A5 JP 2007169302A5 JP 2007083117 A JP2007083117 A JP 2007083117A JP 2007083117 A JP2007083117 A JP 2007083117A JP 2007169302 A5 JP2007169302 A5 JP 2007169302A5
Authority
JP
Japan
Prior art keywords
oligosaccharide conjugate
menc
hib
sequential administration
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007083117A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007169302A (ja
JP4871770B2 (ja
Filing date
Publication date
Priority claimed from GB9422096A external-priority patent/GB9422096D0/en
Application filed filed Critical
Publication of JP2007169302A publication Critical patent/JP2007169302A/ja
Publication of JP2007169302A5 publication Critical patent/JP2007169302A5/ja
Application granted granted Critical
Publication of JP4871770B2 publication Critical patent/JP4871770B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007083117A 1994-11-02 2007-03-27 組み合わせ髄膜炎ワクチン Expired - Fee Related JP4871770B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422096.9 1994-11-02
GB9422096A GB9422096D0 (en) 1994-11-02 1994-11-02 Combined meningitis vaccine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51517596A Division JP3989951B2 (ja) 1994-11-02 1995-11-02 組み合わせ髄膜炎ワクチン

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010236921A Division JP2011016850A (ja) 1994-11-02 2010-10-21 組み合わせ髄膜炎ワクチン

Publications (3)

Publication Number Publication Date
JP2007169302A JP2007169302A (ja) 2007-07-05
JP2007169302A5 true JP2007169302A5 (enExample) 2007-08-16
JP4871770B2 JP4871770B2 (ja) 2012-02-08

Family

ID=10763774

Family Applications (3)

Application Number Title Priority Date Filing Date
JP51517596A Expired - Fee Related JP3989951B2 (ja) 1994-11-02 1995-11-02 組み合わせ髄膜炎ワクチン
JP2007083117A Expired - Fee Related JP4871770B2 (ja) 1994-11-02 2007-03-27 組み合わせ髄膜炎ワクチン
JP2010236921A Withdrawn JP2011016850A (ja) 1994-11-02 2010-10-21 組み合わせ髄膜炎ワクチン

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51517596A Expired - Fee Related JP3989951B2 (ja) 1994-11-02 1995-11-02 組み合わせ髄膜炎ワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010236921A Withdrawn JP2011016850A (ja) 1994-11-02 2010-10-21 組み合わせ髄膜炎ワクチン

Country Status (12)

Country Link
US (1) US6251401B1 (enExample)
EP (3) EP2204185A1 (enExample)
JP (3) JP3989951B2 (enExample)
AT (1) ATE246936T1 (enExample)
CA (2) CA2689871A1 (enExample)
CY (1) CY2423B1 (enExample)
DE (1) DE69531501T3 (enExample)
DK (1) DK0789587T4 (enExample)
ES (1) ES2204967T5 (enExample)
GB (1) GB9422096D0 (enExample)
PT (1) PT789587E (enExample)
WO (1) WO1996014086A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
DE69708318T3 (de) 1996-08-27 2006-11-16 Novartis Vaccines and Diagnostics, Inc., Emeryville Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
AU750702B2 (en) * 1997-05-01 2002-07-25 Chiron Corporation Use of virus-like particles as adjuvants
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
PT1849860E (pt) * 1997-05-28 2011-02-23 Novartis Vaccines & Diagnostic Processo de preparação de um factor imunogénico de corynebacterium diphtheriae utilizando um meio de cultura com extracto de levedura como fonte de aminoácidos e sem complexos proteicos de origem animal
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
EP2292263A3 (en) * 1999-12-02 2011-07-27 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for stabilizing biological molecules upon lyophilization
EP1946769B1 (en) * 2000-06-29 2012-05-30 SmithKline Beecham Biologicals S.A. Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
JP2004529643A (ja) 2001-04-17 2004-09-30 カイロン コーポレイション 機能活性抗体を誘発する髄膜炎菌性ｂエピトープの分子模倣物
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
DE60328481D1 (de) * 2002-05-14 2009-09-03 Novartis Vaccines & Diagnostic Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
US20030124139A1 (en) * 2002-11-20 2003-07-03 Irina Esikova Compositions and methods for stabilizing biological molecules upon lyophilization
DK1587537T3 (da) 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
ES2397923T3 (es) 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
GB0500787D0 (en) * 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
HUE045482T2 (hu) 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
IN2009KN04098A (enExample) * 2007-06-04 2015-08-28 Novartis Ag
HRP20120433T1 (en) * 2007-10-19 2012-07-31 Novartis@Ag Meningococcal vaccine formulations
AU2008335457B2 (en) 2007-12-07 2015-04-16 Glaxosmithkline Biologicals S.A. Compositions for inducing immune responses
CA2808975C (en) 2010-08-23 2018-10-30 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
KR101584871B1 (ko) 2010-09-10 2016-01-22 와이어쓰 엘엘씨 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
CA2865745C (en) 2012-03-09 2018-01-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
CA2903716C (en) 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
KR20190049940A (ko) 2015-02-19 2019-05-09 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof
CA3155669A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US5628496A (en) 1995-06-07 1997-05-13 Avm, Inc. Pneumatic spring
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions

Similar Documents

Publication Publication Date Title
JP2006213929A5 (enExample)
IL222346A (en) An immunogenic preparation containing at least two capsular sugars of meningitides n, its use and a vaccine containing it
JP2009524695A5 (enExample)
DK1962899T3 (da) Pneumococcus-polysaccharid-konjugat-vaccine
IL186367A0 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
JP2007522094A5 (enExample)
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
IL203915A (en) Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol
JP2007533729A5 (enExample)
IL200388A (en) Antibody, antibody hybridoma, antibody-containing conjugate, antibody-containing drug and / or conjugate and their uses
JP2009538898A5 (enExample)
PT2167121E (pt) Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae
JP2007520565A5 (enExample)
JP2006305390A5 (enExample)
GB2452696B (en) 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2007083190A8 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
JP2008104450A5 (enExample)
EP2076125A4 (en) MODIFIED NDGA DERIVATIVES FROM TETRA-O-SUBSTITUTED BUTANE BRIDGE, THEIR SYNTHESIS AND PHARMACEUTICAL USE
JP2008519810A5 (enExample)
EP2292241A4 (en) SCUTELLARIN DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE
ATE466863T1 (de) Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit
EA200901387A1 (ru) Фармацевтическая композиция, включающая дезлоратадин
FR2896246B1 (fr) Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
JP2009509934A5 (enExample)
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate